214 related articles for article (PubMed ID: 36946615)
1. Serinc5 Restricts HIV Membrane Fusion by Altering Lipid Order and Heterogeneity in the Viral Membrane.
Ward AE; Sokovikova D; Waxham MN; Heberle FA; Levental I; Levental KR; Kiessling V; White JM; Tamm LK
ACS Infect Dis; 2023 Apr; 9(4):773-784. PubMed ID: 36946615
[TBL] [Abstract][Full Text] [Related]
2. SERINC5 Inhibits HIV-1 Infectivity by Altering the Conformation of gp120 on HIV-1 Particles.
Featherstone A; Aiken C
J Virol; 2020 Sep; 94(20):. PubMed ID: 32796070
[TBL] [Abstract][Full Text] [Related]
3. Aromatic Side Chain at Position 412 of SERINC5 Exerts Restriction Activity toward HIV-1 and Other Retroviruses.
Tan TS; Toyoda M; Tokunaga K; Ueno T
J Virol; 2021 Aug; 95(18):e0063421. PubMed ID: 34190600
[TBL] [Abstract][Full Text] [Related]
4. The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.
Trautz B; Wiedemann H; Lüchtenborg C; Pierini V; Kranich J; Glass B; Kräusslich HG; Brocker T; Pizzato M; Ruggieri A; Brügger B; Fackler OT
J Biol Chem; 2017 Aug; 292(33):13702-13713. PubMed ID: 28659343
[TBL] [Abstract][Full Text] [Related]
5. Super-Resolution Fluorescence Imaging Reveals That Serine Incorporator Protein 5 Inhibits Human Immunodeficiency Virus Fusion by Disrupting Envelope Glycoprotein Clusters.
Chen YC; Sood C; Marin M; Aaron J; Gratton E; Salaita K; Melikyan GB
ACS Nano; 2020 Sep; 14(9):10929-10943. PubMed ID: 32441921
[TBL] [Abstract][Full Text] [Related]
6. HIV-cell membrane fusion intermediates are restricted by Serincs as revealed by cryo-electron and TIRF microscopy.
Ward AE; Kiessling V; Pornillos O; White JM; Ganser-Pornillos BK; Tamm LK
J Biol Chem; 2020 Nov; 295(45):15183-15195. PubMed ID: 32788212
[TBL] [Abstract][Full Text] [Related]
7. HIV envelope tail truncation confers resistance to SERINC5 restriction.
Haider T; Snetkov X; Jolly C
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34001619
[TBL] [Abstract][Full Text] [Related]
8. SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.
Sood C; Marin M; Chande A; Pizzato M; Melikyan GB
J Biol Chem; 2017 Apr; 292(14):6014-6026. PubMed ID: 28179429
[TBL] [Abstract][Full Text] [Related]
9. Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection.
Beitari S; Pan Q; Finzi A; Liang C
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493821
[TBL] [Abstract][Full Text] [Related]
10. CD4 Expression and Env Conformation Are Critical for HIV-1 Restriction by SERINC5.
Zhang X; Shi J; Qiu X; Chai Q; Frabutt DA; Schwartz RC; Zheng YH
J Virol; 2019 Jul; 93(14):. PubMed ID: 31043528
[TBL] [Abstract][Full Text] [Related]
11. SERINC5 Restricts HIV-1 Infectivity by Promoting Conformational Changes and Accelerating Functional Inactivation of Env.
Kirschman J; Marin M; Chen YC; Chen J; Herschhorn A; Smith AB; Melikyan GB
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891369
[TBL] [Abstract][Full Text] [Related]
12. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
Trautz B; Pierini V; Wombacher R; Stolp B; Chase AJ; Pizzato M; Fackler OT
J Virol; 2016 Dec; 90(23):10915-10927. PubMed ID: 27681140
[TBL] [Abstract][Full Text] [Related]
13. Effect of HIV-1 Env on SERINC5 Antagonism.
Beitari S; Ding S; Pan Q; Finzi A; Liang C
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928004
[TBL] [Abstract][Full Text] [Related]
14. Nef homodimers down-regulate SERINC5 by AP-2-mediated endocytosis to promote HIV-1 infectivity.
Staudt RP; Smithgall TE
J Biol Chem; 2020 Nov; 295(46):15540-15552. PubMed ID: 32873704
[TBL] [Abstract][Full Text] [Related]
15. Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins.
Ahi YS; Zhang S; Thappeta Y; Denman A; Feizpour A; Gummuluru S; Reinhard B; Muriaux D; Fivash MJ; Rein A
mBio; 2016 Nov; 7(6):. PubMed ID: 27879338
[TBL] [Abstract][Full Text] [Related]
16. Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5.
Schulte B; Selyutina A; Opp S; Herschhorn A; Sodroski JG; Pizzato M; Diaz-Griffero F
Virology; 2018 Feb; 515():52-65. PubMed ID: 29268082
[TBL] [Abstract][Full Text] [Related]
17. Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity.
Nkuwi E; Judicate GP; Tan TS; Barabona G; Toyoda M; Sunguya B; Kamori D; Ueno T
J Virol; 2023 Oct; 97(10):e0082323. PubMed ID: 37768085
[TBL] [Abstract][Full Text] [Related]
18. SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV.
Gonzalez-Enriquez GV; Escoto-Delgadillo M; Vazquez-Valls E; Torres-Mendoza BM
J Immunol Res; 2017; 2017():1548905. PubMed ID: 29359168
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Nef Antagonizes SERINC5 Restriction by Downregulation of SERINC5 via the Endosome/Lysosome System.
Shi J; Xiong R; Zhou T; Su P; Zhang X; Qiu X; Li H; Li S; Yu C; Wang B; Ding C; Smithgall TE; Zheng YH
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514909
[TBL] [Abstract][Full Text] [Related]
20. Coelacanth
Ramdas P; Bhardwaj V; Singh A; Vijay N; Chande A
J Virol; 2021 Jun; 95(13):e0022921. PubMed ID: 33883219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
